Cross Labeling Oncology Drugs in Combination Regimens Guidance for Industry
Docket Number: FDA-2020-D-2107 Issued by: Guidance Issuing Office Center for Biologics Evaluation and Research Center for Drug Evaluation and Research, Office of New Drugs Drug approvals in oncology often build on treatment effects by adding drugs to …